Jazz Pharmaceuticals Announces Third Quarter 2021 Financial Results And Raises Full Year Earnings Guidance
Go back to Jazz Pharmaceuticals Announces Third Quarter 2021 Financial Results And Raises Full Year Earnings Guidance| JAZZ PHARMACEUTICAL (NASDAQ: JAZZ) | Delayed: 244.17 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $244.17 | 52 Week High | $160.00 | |||
| Open | $244.17 | 52 Week Low | $95.80 | |||
| Day High | $244.17 | P/E | 45.38 | |||
| Day Low | $244.17 | EPS | $5.38 | |||
| Volume | 29 | |||||
